Pfizer enters exclusive global, ex-China licensing pact with 3SBio for development, manufacturing & commercialization of ...
Pfizer Inc. announced it has entered into an exclusive global, ex-China, licensing agreement with 3SBio, Inc., a leading Chinese biopharmaceutical company, for the development, manufacturing and commercialization of SSGJ-707, a bispecific antibody …